SCHEMBL13475911

SCHEMBL13475911

COC(=O)c1ccc(-c2nc3sc(C#N)c(C)c3c(=O)[nH]2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 1/20 0.49
ALDH1A1 P00352 5/20 0.46
MAPT P10636 3/20 0.46
GAA P10253 2/20 0.46
KDM4C Q9H3R0 1/20 0.46
KDM4E B2RXH2 4/20 0.45
HPGD P15428 3/20 0.45
HSD17B10 Q99714 1/20 0.45
WNT3A P56704 1/20 0.44
TNKS2 Q9H2K2 1/20 0.44
RHEB Q15382 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 2/20 0.44
NPC1 O15118 1/20 0.44
PKM P14618 1/20 0.44
NFKB1 P19838 1/20 0.44
RAB9A P51151 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
MMP2 P08253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2839683 0.84 CDKN1A (0.56) TNKSALDH1A1MAPTGAAKDM4E
SCHEMBL2843704 0.84 KDM4E (0.50) TNKSALDH1A1KDM4EHPGDHSD17B10
SCHEMBL2843024 0.82 TMIGD3 (0.46) TNKSALDH1A1MAPTKDM4EHPGD
SCHEMBL2837248 0.82 ALDH1A1 (0.61) ALDH1A1GAAKDM4EHPGDHSD17B10
SCHEMBL2838028 0.81 ALDH1A1 (0.57) ALDH1A1MAPTKDM4EHPGDHSD17B10
SCHEMBL13475914 0.80 TMIGD3 (0.45) ALDH1A1KDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL2833833 0.80 FGFR1 (0.52) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL2837355 0.79 BRD4 (0.55) TNKSALDH1A1KDM4EHPGDHSD17B10
SCHEMBL2837954 0.78 TNKS (0.47) TNKSALDH1A1MAPTKDM4EHPGD
SCHEMBL2839494 0.77 ALDH1A1 (0.43) ALDH1A1MAPTGAAKDM4CKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662814-B2 4-(4-Ethylpiperazin-1-yl)-5-methyl-2-phenylthieno[2,3-d]pyrimidine-6-carbonitrile; asthma, atopic dermatitis, chronic obstructive pulmonary disease, Crohn's disease, type I and type II diabetes, lymphoid leukemia and other forms of cancer, multiple sclerosis and autoimmune diseases LABORATORIOS ALMIRALL, S.A. (ES) 2010-02-16 US disclosed